PRISTIQ (nda021992)- (EQ 50MG BASE,EQ 100MG BASE,EQ 25MG BASE)

Generic Name	DESVENLAFAXINE SUCCINATE	Innovator	PF PRISM CV
Dosage	EQ 50MG BASE,EQ 100MG BASE,EQ 25MG BASE
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2027-Jul-05	NCE Excl Expiry	2013-Mar-01
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	PRISTIQ is a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD)

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
9	0	8

Other Developers

Total Other Developers	11

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 50MG BASE	**	**	Down	-	6
EQ 100MG BASE	**	**	Down	-	6
EQ 25MG BASE	**	**	Down	-	6

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	7

Manufacturing Details of PRISTIQ